8% Off
Feripon500 mg
Drug International Ltd.
৳165.60
Add to cart
Best PriceTk 11.25/piece
Out Of Stock1
Alternatives
Price
Medicine overview
Indications of Defera 500 mg
Defera 500 mg is indicated for the treatment of iron overload patients with thalassemia major when deferoxamine therapy is contraindicated or inadequate. Defera 500 mg therapy should be initiated and maintained by a physician experienced in the treatment of patients with thalassemia.
Theropeutic Class
Antidote preparations
Pharmacology
Defera 500 mg is a chelating agent with an affinity for ferric ion (iron III). Defera 500 mg binds with ferric ions to form neutral 3:1 (Defera 500 mg:iron) complexes that are stable over a wide range of pH values. Defera 500 mg has a lower binding affinity for other metals such as copper, aluminum and zinc than for iron.
Dosage & Administration of Defera 500 mg
Adult: 25 mg/kg tid. Doses >100 mg/kg daily are not recommended.Child: >6 yr: 25 mg/kg tid.May be taken with or without food.
Dosage of Defera 500 mg
In adults and children over 6 years: this medicine may be given by mouth in doses of 25mg/kg three times daily. Doses above 100mg/kg daily are not recommended. Or, as directed by the registered physician.
Interaction of Defera 500 mg
The safety of concurrent use of Defera 500 mg and Vitamin C has not been formally studied. Based on the reported adverse interaction that can occur between deferoxamine and Vitamin C, caution should be used when administering concurrent Defera 500 mg and Vitamin C. It should not be given with aluminium containing antacids.
Contraindications
It is contraindicated for hypersensitivity to the active substance or any of the excipients.
Side Effects of Defera 500 mg
Gastrointestinal disorders such as diarrhoea, nausea, vomiting and abdominal pain are common during Defera 500 mg treatment and may require temporary reduction in dose. A reddish brown discoloration of the urine is also common. Other adverse effects that have been reported include arthralgia and increased liver enzymes.
Pregnancy & Lactation
Pregnancy Category D. There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Precautions & Warnings
Defera 500 mg has been shown to cause neutropenia including agranulocytosis. The patients neutrophil count should be monitored every week. Caution is advised in patients with hepatic or renal impairment.
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Drug Classes
Antidote preparations
Mode Of Action
Defera 500 mg is a chelating agent with an affinity for ferric ion (iron III). Defera 500 mg binds with ferric ions to form neutral 3:1 (Defera 500 mg:iron) complexes that are stable over a wide range of pH values. Defera 500 mg has a lower binding affinity for other metals such as copper, aluminum and zinc than for iron.
Pregnancy
Defera 500 mg is not recommended for use in pregnant & lactating women.
Frequently Asked Questions
What is Defera 500 mg used for?
Defera 500 mg is indicated for the treatment of iron overload patients with thalassemia major when deferoxamine therapy is contraindicated or inadequate. Defera 500 mg therapy should be initiated and maintained by a physician experienced in the treatment of patients with thalassemia.
What is the dosage of Defera 500 mg?
In adults and children over 6 years: this medicine may be given by mouth in doses of 25mg/kg three times daily. Doses above 100mg/kg daily are not recommended. Or, as directed by the registered physician.
What are the side effects of Defera 500 mg?
Gastrointestinal disorders such as diarrhoea, nausea, vomiting and abdominal pain are common during Defera 500 mg treatment and may require temporary reduction in dose. A reddish brown discoloration of the urine is also common. Other adverse effects that have been reported include arthralgia and increased liver enzymes.
Who should not take Defera 500 mg?
It is contraindicated for hypersensitivity to the active substance or any of the excipients.
What precautions should be taken with Defera 500 mg?
Defera 500 mg has been shown to cause neutropenia including agranulocytosis. The patients neutrophil count should be monitored every week. Caution is advised in patients with hepatic or renal impairment.
Is Defera 500 mg safe during pregnancy and breastfeeding?
Pregnancy Category D. There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.